Figure 1 Change from baseline in DYS and NMPP scores from 1 to 6 months…
Advancements to the Most Deployed ZTNA Solution Strengthen the Zscaler Zero Trust Exchange with New…
Dubai, United Arab Emirates–(Newsfile Corp. – March 22, 2022) – Top cryptocurrency exchange LBank’s CEO…
LONDON & DENVER–(BUSINESS WIRE)–AtlasEdge, a pan-European edge data centre provider, today confirmed the selection of…
Insta360 engineered their ONE RS action camera to connect to a 360° module, a weatherproof…
Platform will enable faster credit decisions and increased credit access across customer segments NEW YORK–(BUSINESS…
MELBOURNE, Australia and BRUSSELS, Belgium, March 22, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
GUANGZHOU, China, March 21, 2022 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
MALVERN, Pa., March 21, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biopharmaceutical company…
Announced during HIMSS 2022, Solodev now offers a serverless solution for enterprise-grade healthcare organizations to…
NEW YORK–(BUSINESS WIRE)–KKR Real Estate Finance Trust Inc. (“KREF”) (NYSE: KREF) today announced the tax…
LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a…
MELBOURNE, Australia–(BUSINESS WIRE)–#ReshapingCX–Alvaria and Call Design announce a new Alvaria Workforce customer, TSA Group. Australia’s…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 24 classes of mortgage pass-through certificates from J.P….
Orphazyme A/SCompany announcementNo. 12/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 21, 2022 – Orphazyme A/S…
BILLERICA, Mass., March 21, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:…
FORT COLLINS, Colo., March 21, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
– VRDN-002 incorporates clinically validated half-life extension technology to support development as a low volume…
Company to undergo a strategic portfolio review while continuing to execute on the development of…
On track to deliver topline proof-of-concept data from Phase 1 clinical trial of oral IL-17…